The Infectious Diseases Society of America (IDSA) listed six steps to help clinicians prescribe the COVID-19 medication while minimizing interaction risks. Other recent research looked at neuropsychiatric conditions after COVID-19 and hospital
Retrospective data from Israel showed that in people ages 60 years and older, an additional booster dose of the Pfizer-BioNTech COVID-19 vaccine was 55% effective against symptomatic disease and 68% effective against hospitalization.
COVID-19-related disparities were also in the news this week.
The FDA gave the Novavax COVID-19 vaccine emergency use authorization for adults. One recent review found lower myocarditis risk with the Pfizer-BioNTech vaccine than the Moderna vaccine, and another looked at the strength of evidence supporting
The coronavirus disease 2019 (COVID-19) pandemic has brought palliative care to the forefront of internal medicine. ... As the novel coronavirus makes more patients seriously ill, with common symptoms including acute shortness of breath, physicians have
Hey, Dr. Fincher, I understand you're on the Georgia governor's coronavirus task force.
They talked about their first patients with potential coronavirus symptoms, when they knew that they would have to close their physical doors, and the rapid-fire move to treating most patients ... We don't want to have to deal with a second wave of
https://acpinternist.org/archives/2021/01/treating-the-lingering-effects-of-covid-19.htm. An expert offered tips on helping patients who catch the novel coronavirus and then can't shake
O’Connell said. “With the frequency of co-occurring medical and psychiatric vulnerabilities in our homeless population, we knew coronavirus would be a very devastating disease for our folks.”.
The Coronavirus Treatment Acceleration Program aims to bring treatments to market as quickly as possible while supporting research to further evaluate whether they are safe and effective for treating patients with ... the coronavirus.